BRK-B vs HERZ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HERZ exhibits severe financial instability, highlighted by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis with a current ratio of 0.05. While the stock trades at a discount to book value (P/B 0.75), it is significantly overpriced relative to its Graham Number ($9.81) and Intrinsic Value ($1.40). The most alarming factor is the unsustainable dividend yield of 57.69% with a payout ratio exceeding 1100%, characterizing this as a classic dividend trap. Despite strong revenue growth, the collapse in earnings (-73% YoY) and negative profit margins indicate a failing operational model.
Compare Another Pair
Related Comparisons
BRK-B vs HERZ: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Herzfeld Credit Income Fund, Inc. (HERZ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.